Lantheus Holdings Inc (LNTH)
65.21
+0.80
(+1.24%)
USD |
NASDAQ |
Apr 24, 16:00
65.23
+0.02
(+0.03%)
After-Hours: 20:00
Lantheus Holdings Cash from Investing (Quarterly): -12.07M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -12.07M |
| September 30, 2023 | 83.22M |
| June 30, 2023 | -20.70M |
| March 31, 2023 | -44.51M |
| December 31, 2022 | -264.72M |
| September 30, 2022 | -6.09M |
| June 30, 2022 | -4.343M |
| March 31, 2022 | -1.39M |
| December 31, 2021 | -4.544M |
| September 30, 2021 | -2.42M |
| June 30, 2021 | -2.656M |
| March 31, 2021 | 13.30M |
| December 31, 2020 | -3.785M |
| September 30, 2020 | -3.736M |
| June 30, 2020 | 5.307M |
| March 31, 2020 | -2.698M |
| December 31, 2019 | -4.741M |
| September 30, 2019 | -3.336M |
| June 30, 2019 | -3.434M |
| March 31, 2019 | -10.55M |
| December 31, 2018 | -7.366M |
| September 30, 2018 | -5.005M |
| Date | Value |
|---|---|
| June 30, 2018 | -5.626M |
| March 31, 2018 | -1.135M |
| December 31, 2017 | -5.954M |
| September 30, 2017 | -3.288M |
| June 30, 2017 | -2.503M |
| March 31, 2017 | -4.564M |
| December 31, 2016 | -2.358M |
| September 30, 2016 | -1.047M |
| June 30, 2016 | -0.736M |
| March 31, 2016 | 7.422M |
| December 31, 2015 | -4.732M |
| September 30, 2015 | -2.307M |
| June 30, 2015 | -2.614M |
| March 31, 2015 | -3.498M |
| December 31, 2014 | -2.834M |
| September 30, 2014 | -1.595M |
| June 30, 2014 | -1.791M |
| March 31, 2014 | -1.462M |
| December 31, 2013 | 0.228M |
| September 30, 2013 | -0.915M |
| June 30, 2013 | -1.347M |
| March 31, 2013 | -1.449M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-264.72M
Minimum
Dec 2022
83.22M
Maximum
Sep 2023
-14.91M
Average
-3.736M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -0.089M |
| Eli Lilly and Co | -2.924B |
| Boston Scientific Corp | -1.053B |
| NeuroMetrix Inc | 0.098M |
| Stryker Corp | -152.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 112.29M |
| Cash from Financing (Quarterly) | -0.45M |
| Free Cash Flow | 258.70M |
| Free Cash Flow Per Share (Quarterly) | 1.429 |
| Free Cash Flow to Equity (Quarterly) | 99.00M |
| Free Cash Flow to Firm (Quarterly) | 100.22M |
| Free Cash Flow Yield | 5.69% |